Improving reporting of infection events in clinical trials.
作者信息
Ludwig Heinz, Munshi Nikhil C, Terpos Evangelos, Raje Noopur, Moreau Philippe, Nooka Ajay
机构信息
Wilhelminen Cancer Research Institute, Department of Medicine I, Clinic Ottakring, Vienna, Austria.
Dana-Farber Cancer Institute and Boston VA Healthcare System, Boston, MA.
出版信息
Blood Adv. 2024 Nov 26;8(22):5927-5928. doi: 10.1182/bloodadvances.2024014102.
Abstract
摘要
相似文献
1
Improving reporting of infection events in clinical trials.改善临床试验中感染事件的报告。
Blood Adv. 2024 Nov 26;8(22):5927-5928. doi: 10.1182/bloodadvances.2024014102.
2
Quality of reporting of adverse events in clinical trials of covid-19 drugs: systematic review.新冠病毒疾病药物临床试验中不良事件报告的质量：系统评价
BMJ Med. 2023 Sep 21;2(1):e000352. doi: 10.1136/bmjmed-2022-000352. eCollection 2023.
3
Improving the capture and reporting of adverse events in clinical trials of non-pharmacological interventions: learnings from the PaCCSC/CST membership.改善非药物干预临床试验中不良事件的捕获与报告：来自PaCCSC/CST成员的经验教训
Trials. 2025 Mar 18;26(1):95. doi: 10.1186/s13063-025-08801-1.
4
Evolution of Hematology Clinical Trial Adverse Event Reporting to Improve Care Delivery.血液学临床试验不良事件报告的演变，以改善护理服务。
Curr Hematol Malig Rep. 2021 Apr;16(2):126-131. doi: 10.1007/s11899-021-00627-3. Epub 2021 Mar 30.
5
Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome.二甲双胍与复方口服避孕药治疗多囊卵巢综合征的多毛症、痤疮和月经模式比较
Cochrane Database Syst Rev. 2020 Aug 13;8(8):CD005552. doi: 10.1002/14651858.CD005552.pub3.
6
The reporting of adverse events following spinal manipulation in randomized clinical trials-a systematic review.随机临床试验中脊柱推拿后不良事件的报告——一项系统评价
Spine J. 2016 Sep;16(9):1143-51. doi: 10.1016/j.spinee.2016.05.018. Epub 2016 May 27.
7
Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse events.随机临床试验中伤害选择性报告的机会：非系统性不良事件的选择标准。
Trials. 2019 Sep 5;20(1):553. doi: 10.1186/s13063-019-3581-3.
8
Online monitoring of patient self-reported adverse events in early phase clinical trials: Views from patients, clinicians, and trial staff.在线监测早期临床试验中患者自报告的不良事件：来自患者、临床医生和试验人员的观点。
Clin Trials. 2021 Apr;18(2):168-179. doi: 10.1177/1740774520972125. Epub 2020 Nov 24.
9
Improving adverse drug event reporting by healthcare professionals.提高医疗保健专业人员对药物不良事件的报告率。
Cochrane Database Syst Rev. 2024 Oct 29;10(10):CD012594. doi: 10.1002/14651858.CD012594.pub2.
10
Ivermectin for preventing and treating COVID-19.伊维菌素预防和治疗 COVID-19。
Cochrane Database Syst Rev. 2022 Jun 21;6(6):CD015017. doi: 10.1002/14651858.CD015017.pub3.
引用本文的文献
1
Novelties on Multiple Myeloma from the Main 2024 Hematology Conferences.2024年主要血液学会议上多发性骨髓瘤的新进展。
Mediterr J Hematol Infect Dis. 2025 Mar 1;17(1):e2025027. doi: 10.4084/MJHID.2025.027. eCollection 2025.
本文引用的文献
1
Improving infection reporting in hematology treatment trials.改善血液学治疗试验中的感染报告。
Blood Adv. 2024 Nov 26;8(22):5925-5926. doi: 10.1182/bloodadvances.2024013859.
2
Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysis.多发性骨髓瘤中使用双特异性抗体相关感染风险：汇总分析。
Blood Adv. 2023 Jul 11;7(13):3069-3074. doi: 10.1182/bloodadvances.2022009435.
3
B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches.B 细胞成熟抗原（BCMA）在多发性骨髓瘤中的作用：靶向治疗的原理和当前的治疗方法。
Leukemia. 2020 Apr;34(4):985-1005. doi: 10.1038/s41375-020-0734-z. Epub 2020 Feb 13.
Zotero 插件